IVERIC bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

IVERIC bio, Inc. (Nasdaq: ISEE) will have CEO Glenn P. Sblendorio present at the 39^th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 2:50 p.m. Eastern Time via a virtual session. Investors and the public can access the live webcast on IVERIC bio's website, with a replay available for two weeks post-conference. The company focuses on developing innovative treatments for retinal diseases, emphasizing their commitment to finding solutions for conditions with significant unmet medical needs.

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will present an overview of the Company at the 39^th Annual J.P. Morgan Healthcare Conference in a virtual session on Thursday, January 14, 2021 at 2:50 p.m. Eastern Time.

Investors and the general public are invited to listen to a live webcast of the presentation on the Investor / Events & Presentations section of the IVERIC bio website at www.ivericbio.com. An archived replay of the webcast will be available on the Company’s website immediately following the conference and for at least two weeks thereafter.

About IVERIC bio

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. Vision is Our Mission. For more information on the Company please visit www.ivericbio.com.

Forward-looking Statements

Any statements in this press release about IVERIC bio’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent IVERIC bio’s views only as of the date of this press release. IVERIC bio anticipates that subsequent events and developments will cause its views to change. While IVERIC bio may elect to update these forward-looking statements at some point in the future, IVERIC bio specifically disclaims any obligation to do so.

ISEE-G

View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005168/en/

FAQ

When will IVERIC bio present at the J.P. Morgan Healthcare Conference?

IVERIC bio, Inc. will present on January 14, 2021, at 2:50 p.m. Eastern Time.

How can I access IVERIC bio's conference presentation?

You can access the live webcast of IVERIC bio's presentation on their website under the Investor / Events & Presentations section.

What is the focus of IVERIC bio's development efforts?

IVERIC bio focuses on discovering and developing novel treatments for retinal diseases.

Where can I find the archived presentation of IVERIC bio's conference?

The archived presentation will be available on IVERIC bio's website immediately after the conference and for at least two weeks.

What stock symbol does IVERIC bio operate under?

IVERIC bio operates under the stock symbol ISEE.